“We need to engage with key players in the healthcare system, secure support among prescribers, and position Diamyd Medical effectively within the U.S. market,” says Diamyd Medical board member Karin Rosen, MD PhD.
Read the article hereSilicon Valley Nordic Beat summarizes the webcast on November 14 where CEO Ulf Hannelius, Board Member Karin Rosen MD, PhD, and Head of Business Development Sofia Mayans presented the company.
See full webcast (in Swedish) here: